Mid‐Term Clinical Outcomes According to CTO Revascularization Status in Patients With NSTEMI and Multivessel Disease
Open Access
- 22 October 2026
- journal article
- Published by Wiley in Clinical Cardiology
- Vol. 49 (10)
Abstract
Background: The clinical relevance of chronic total occlusion (CTO) revascularization in patients with non–ST‐segment elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) remains uncertain. Methods: In this multicenter retrospective cohort study, 632 patients with NSTEMI, MVD, and CTO were included. Patients were categorized into a complete revascularization group involving successful CTO recanalization (CR‐CTO, n = 119) and an incomplete revascularization group without successful CTO recanalization (ICR‐CTO, n = 513). The primary endpoints were major adverse cardiovascular and cerebrovascular events (MACCE) and major adverse cardiovascular events (MACE). Results: During a mean follow‐up of 528 ± 201 days, the incidences of MACCE (11.8% vs. 28.5%) and MACE (7.6% vs. 24.2%) were significantly lower in the CR‐CTO group than in the ICR‐CTO group (both p < 0.001). In multivariable Cox regression analyses, CR‐CTO was independently associated with lower risks of MACCE (hazard ratio [HR], 0.35; 95% confidence interval [CI], 0.20–0.61) and MACE (HR, 0.26; 95% CI, 0.13–0.51). Among patients without successful CTO recanalization, additional revascularization of non‐CTO lesions was not associated with improved outcomes. Conclusions: In patients with NSTEMI, MVD, and CTO, complete revascularization involving successful CTO recanalization was associated with improved mid‐term clinical outcomes. In contrast, additional revascularization of non‐CTO lesions alone was not associated with a prognostic benefit when CTO lesions remained unrevascularized. These findings suggest that CTO revascularization status may warrant specific consideration when revascularization strategies are evaluated in this patient population.Keywords
This publication has 30 references indexed in Scilit:
- Myocardial infarction in multivessel disease: Does presence of chronic total occlusion make a difference?International Journal of Cardiology, 2025
- A comparison of long‐term clinical outcomes between percutaneous coronary intervention (PCI) and medical therapy in patients with chronic total occlusion in noninfarct‐related artery after PCI of acute myocardial infarctionClinical Cardiology, 2022
- Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trialAmerican Heart Journal, 2021
- A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total OcclusionJACC: Cardiovascular Interventions, 2018
- Impact of chronic total occlusion in a non-infarct-related coronary artery on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarctionInternational Journal of Cardiology, 2018
- Impact of multi-vessel versus single-vessel disease on outcomes after percutaneous coronary interventions for chronic total occlusionsClinical Research in Cardiology, 2017
- Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMIJACC, 2016
- Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non–Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry)The American Journal of Cardiology, 2016
- Impact of chronic total occlusion artery on 12-month mortality in patients with non-ST-segment elevation myocardial infarction treated by percutaneous coronary intervention (From the PL-ACS Registry)International Journal of Cardiology, 2013
- The Negative Impact of Incomplete Angiographic Revascularization on Clinical Outcomes and Its Association With Total OcclusionsJACC, 2013